Fortis Healthcare Ltd.
FORTIS · NSE · Healthcare
With a 20% margin of safety, our buy-below price is ₹312.64.
Piotroski F-score 6/9 — quality of earnings & balance sheet.
Investability checklist
- ✕ROE above 15%11.0%
- ✓Low debt (D/E < 0.5)0.34x
- ✓Positive free cash flow
- ✓Revenue growth > 10%18%
- ✓Earnings growing44%
- ✓Net margin ≥ 10%11.4%
- ✕Current ratio > 1.50.86
- ✕Below our fair value
- ✕Margin of safety ≥ 20%
- ✓Above 200-day average
- ✓Above 50-day average
- –Positive 1-year return
- ✓Altman Z in safe zoneZ 8.26
- ✕Piotroski ≥ 76/9
1-year price
EOD · 2026-06-15Our scores
Key fundamentals
SWOT snapshot
Strengths
- •Lightly leveraged balance sheet.
- •Financially solid — Altman Z 8.26.
Opportunities
- •Earnings growing (44% YoY).
- •Revenue growing (18% YoY).
Threats
- •Trades ~60% above our estimated fair value.
About Fortis Healthcare Ltd.
Fortis Healthcare Limited operates as a healthcare delivery service provider in India. The company offers services in the areas of cardiac science, critical care, vascular surgery, dental science, dermatology, diabetology/endocrinology, emergency and trauma, geriatric medicine, liver transplant and hepatobiliary sciences, pain and palliative medicine, ENT, foetal medicine, gastroenterology and hepatology science, general surgery, and haematology areas. It also provides servic
More in Healthcare
Our verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.